- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02290912
Gray Matters Alzheimer's Disease Prevention Intervention
December 2, 2015 updated by: Maria C Norton, PhD, Utah State University
Gray Matters: Multi-domain Lifestyle Behavioral Alzheimer's Disease Prevention Randomized Controlled Trial
This is a randomized controlled trial to develop and test the efficacy of a multi-domain lifestyle behavioral intervention designed to promote healthier lifestyle behaviors linked to lower Alzheimer's disease risk among persons aged 40 to 64 years.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This is a randomized controlled trial to develop and test the efficacy of a multi-domain lifestyle behavioral intervention designed to promote healthier lifestyle behaviors linked to lower Alzheimer's disease risk among persons aged 40 to 64 years.
Participants are randomized to treatment or control condition.
The intervention, spanning a six month period, is an evidence-based health education program.
Study Type
Interventional
Enrollment (Actual)
146
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 64 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age
- Residing or working in Cache County Utah
- Possessing smart phone or tablet
Exclusion Criteria:
- Dementia
- Pregnancy
- Untreated chronic major depression or other psychiatric condition
- Body mass index > 41
- Heart or stroke in prior 6 weeks
- Active cancer treatment
- Unwillingness to seek medical help when serious condition identified at intake
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control
No intervention
|
|
Experimental: Treatment
Health education program; informational website, experiential classes in various help domains, custom smart phone application, and wearable technology
|
The intervention is a health education program including: informational website, experiential classes, custom smart phone or smart table application, wearable activity monitor, and informal coaching by student researchers to provide moral support for lifestyle behavioral change goals.
Participants are not placed on any specific behavioral regimen but instead are encouraged to adopt healthier lifestyle behaviors per the evidence-based health education program, and to attend the experiential classes "cafeteria style" (i.e. based on their individual preferences).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Picture Vocabulary
Time Frame: up to 7 months
|
Picture Vocabulary cognitive test score
|
up to 7 months
|
Flanker Inhibitory Control and Attention Test
Time Frame: up to 7 months
|
Flanker Inhibitory Control and Attention Test cognitive test score
|
up to 7 months
|
List Sorting Working Memory Test
Time Frame: up to 7 months
|
List Sorting Working Memory Test cognitive test score
|
up to 7 months
|
Oral Symbol Digit Test
Time Frame: up to 7 months
|
Oral Symbol Digit Test cognitive test score
|
up to 7 months
|
Montreal Cognitive Assessment
Time Frame: up to 7 months
|
Montreal Cognitive Assessment test score
|
up to 7 months
|
Rey Auditory Verbal Learning Test
Time Frame: up to 7 months
|
Rey Auditory Verbal Learning Test score
|
up to 7 months
|
Controlled Oral Word Association Test
Time Frame: up to 7 months
|
Controlled Oral Word Association Test score
|
up to 7 months
|
Blood pressure
Time Frame: up to 7 months
|
Systolic and diastolic blood pressure
|
up to 7 months
|
Body mass index
Time Frame: up to 7 months
|
Height and weight measurement for computing body mass index
|
up to 7 months
|
Insulin
Time Frame: up to 7 months
|
insulin from venipuncture blood sample
|
up to 7 months
|
Systemic inflammation
Time Frame: up to 7 months
|
C-reactive protein from venipuncture blood sample
|
up to 7 months
|
Skin carotenoid status
Time Frame: up to 7 months
|
Biophotonic device that shines a light-emitting diode (LED) light at a site on the palm, to measure the skin carotenoid level in units of Raman counts
|
up to 7 months
|
Triglycerides
Time Frame: up to 7 months
|
triglycerides from venipuncture blood sample
|
up to 7 months
|
HDL Cholesterol
Time Frame: up to 7 months
|
High-density lipoprotein from venipuncture blood sample
|
up to 7 months
|
LDL Cholesterol
Time Frame: up to 7 months
|
Low-density lipoprotein from venipuncture blood sample
|
up to 7 months
|
Total cholesterol
Time Frame: up to 7 months
|
Total cholesterol from venipuncture blood sample
|
up to 7 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Depression
Time Frame: up to 7 months
|
Center for Epidemiologic Studies - Depression scale score
|
up to 7 months
|
Motivation
Time Frame: up to 7 months
|
Situational Motivation Scale score
|
up to 7 months
|
Sleep Quality
Time Frame: up to 7 months
|
Pittsburgh Sleep Quality Index scale score
|
up to 7 months
|
Stress
Time Frame: up to 7 months
|
Perceived Stress Scale score
|
up to 7 months
|
Emotional Support
Time Frame: up to 7 months
|
Emotional Support subscale from the NIH Toolbox measures for social engagement
|
up to 7 months
|
Friendship
Time Frame: up to 7 months
|
Friendship subscale from the NIH Toolbox measures for social engagement
|
up to 7 months
|
Hostility
Time Frame: up to 7 months
|
Hostility subscale from the NIH Toolbox measures for social engagement
|
up to 7 months
|
Loneliness
Time Frame: up to 7 months
|
Loneliness subscale from the NIH Toolbox measures for social engagement
|
up to 7 months
|
Physical Activity - Moderate
Time Frame: up to 7 months
|
self-report question concerning # minutes per day doing moderate intensity physical activity (per Center for Disease Control definition)
|
up to 7 months
|
Physical Activity - Vigorous
Time Frame: up to 7 months
|
self-report question concerning # minutes per day doing vigorous intensity physical activity (per Center for Disease Control definition)
|
up to 7 months
|
Nutrition
Time Frame: up to 7 months
|
Diet History Questionnaire
|
up to 7 months
|
Readiness for Change
Time Frame: up to 7 months
|
Revised University of Rhode Island Change Assessment (R-URICA) readiness for change scale
|
up to 7 months
|
Metacognition
Time Frame: up to 7 months
|
Total score from a set of seven items (1=much worse to 5=much better), comparing current memory to how it was three years ago, adapted from a questionnaire of functional ability
|
up to 7 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Maria C Norton, PhD, Utah State University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2014
Primary Completion (Actual)
December 1, 2014
Study Completion (Actual)
December 1, 2014
Study Registration Dates
First Submitted
November 6, 2014
First Submitted That Met QC Criteria
November 10, 2014
First Posted (Estimate)
November 14, 2014
Study Record Updates
Last Update Posted (Estimate)
December 3, 2015
Last Update Submitted That Met QC Criteria
December 2, 2015
Last Verified
December 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 5606
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alzheimer's Disease
-
University of Southern CaliforniaAlzheimer's Therapeutic Research Institute; American Heart Association; Schaeffer...RecruitingDementia | Alzheimer Disease | Prodromal Alzheimer's Disease | Preclinical Alzheimer's DiseaseUnited States
-
University of Southern CaliforniaNational Institute on Aging (NIA); Alzheimer's Therapeutic Research Institute; Brigham and Women's Hospital and other collaboratorsActive, not recruitingDementia | Alzheimer Disease | Prodromal Alzheimer's Disease | Preclinical Alzheimer's DiseaseUnited States
-
Novoic LimitedRecruitingAlzheimer Disease | Mild Cognitive Impairment | Prodromal Alzheimer's Disease | Alzheimer's Disease (Incl Subtypes) | Preclinical Alzheimer's DiseaseUnited States
-
Novoic LimitedRecruitingAlzheimer Disease | Mild Cognitive Impairment | Prodromal Alzheimer's Disease | Alzheimer's Disease (Incl Subtypes) | Preclinical Alzheimer's DiseaseUnited Kingdom
-
Novoic LimitedCompletedAlzheimer Disease | Mild Cognitive Impairment | Prodromal Alzheimer's Disease | Alzheimer's Disease (Incl Subtypes) | Preclinical Alzheimer's DiseaseUnited States
-
Novoic LimitedCompletedAlzheimer Disease | Mild Cognitive Impairment | Prodromal Alzheimer's Disease | Alzheimer's Disease (Incl Subtypes) | Preclinical Alzheimer's DiseaseUnited Kingdom
-
Novoic LimitedRecruitingAlzheimer Disease | Mild Cognitive Impairment | Prodromal Alzheimer's Disease | Alzheimer's Disease (Incl Subtypes) | Preclinical Alzheimer's DiseaseUnited Kingdom
-
Novoic LimitedRecruitingAlzheimer Disease | Mild Cognitive Impairment | Prodromal Alzheimer's Disease | Alzheimer's Disease (Incl Subtypes) | Preclinical Alzheimer's Disease | Normal CognitionUnited States
-
University Hospital, BordeauxMinistry for Health and Solidarity, FranceCompletedAlzheimer's Disease (AD) | Alzheimer's Disease (AD) Related DisordersFrance
-
University of Colorado, DenverNational Institute on Aging (NIA)Active, not recruitingSuspected Typical Alzheimer's Disease (AD) | Suspected Atypical Alzheimer's Disease (AD)United States
Clinical Trials on Health education program
-
University of Southern CaliforniaChildren's Hospital Los AngelesActive, not recruitingObesityUnited States
-
Ghana Health ServicesKwame Nkrumah University of Science and TechnologyNot yet recruitingSmoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking Behaviors
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR)RecruitingOlder Adults | Limitation, MobilityCanada
-
Nantes University HospitalInstitut de Recherche en Santé Publique, FranceUnknown
-
Taibah UniversityUnknown
-
US Department of Veterans AffairsCompleted
-
University of Sao Paulo General HospitalInCor Heart InstituteCompleted
-
Assiut UniversityNot yet recruitingOccupational Exposure | Health Knowledge, Attitudes, Practice
-
National Research Centre, EgyptScience and Technology Development Fund (STDF)CompletedDiabetes Mellitus, Type 2Egypt
-
Johns Hopkins UniversityNational Center for Complementary and Integrative Health (NCCIH)CompletedAnxiety | Depressive Symptoms | Post-traumatic Stress SymptomsUnited States